SARS-CoV-2 (2019-nCoV) Spike S2 Antibody, Rabbit PAb, Antigen Affinity Purified (40590-T62)

SARS-CoV-2 (2019-nCoV) Spike S2抗体, Rabbit PAb, Antigen Affinity Purified

抗原名称:SARS-CoV-2 Spike S2
应用:WB, ELISA
标记:Unconjugated

用户验证的应用

经验证应用

项目详情
WB1:1000-1:5000
ELISA1:5000-1:10000

应用说明

IHC, FCM, IF, IP et al. applications haven't been validated. (Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)

推荐稀释说明

Optimal concentrations/dilutions should be determined by the end user.

详细信息

免疫原Recombinant SARS-CoV-2 / 2019-nCoV Spike/S2 Protein (Catalog#40590-V08B)
宿主/亚型Polyclonal Rabbit IgG
抗体类型Polyclonal
产品类型Antibody
克隆号Polyclonal Rabbit IgG
产品形式Liquid
偶联物Unconjugated
纯化方式Protein A & Antigen Affinity
储存缓冲液0.2 μm filtered solution in PBS
储存条件This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
RRIDAB_3073714

特异性

SARS-CoV-2 Spike S2

制备方法

Produced in rabbits immunized with recombinant SARS-CoV-2 / 2019-nCoV Spike/S2 Protein (Catalog#40590-V08B; YP_009724390.1; Ser686-Pro1213). The specific IgG was purified by SARS-CoV-2 / 2019-nCoV Spike/S2 affinity chromatography.

运输条件

This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

背景信息

The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2 (angiotensin-converting enzyme 2), DPP4 (dipeptidyl peptidase-4), APN (aminopeptidase N), CEACAM (carcinoembryonic antigen-related cell adhesion molecule), Sia (sialic acid), O-ac Sia (O-acetylated sialic acid). The spike is essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. It's been reported that SARS-CoV-2 (COVID-19 coronavirus, 2019-nCoV) can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion; Defines the range of the hosts and specificity of the virus; Main component to bind with the neutralizing antibody; Key target for vaccine design; Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate. References Shen S, et al . (2007) Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV. Methods Mol Biol. 379: 127-35. Du L, et al . (2009) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 7 (3): 226-36. Xiao X, et al . (2004) The SARS-CoV S glycoprotein. Cell Mol Life Sci. 61 (19-20): 2428-30.

文献引用 (73)

SARS-related coronavirus S-protein structures reveal synergistic RBM interactions underpinning high-affinity human ACE2 binding.

SARS相关冠状病毒S蛋白结构揭示了RBM的协同相互作用,这种相互作用支撑着高亲和力的人类ACE2结合

Wang Jingjing, Ma Yong, Li Zimu, Yuan Hang, Liu Banghui, Li Zexuan, Su Mengzhen, Habib Gul, Liu Yutong, Fu Lutang, Wang Peiyi, Li Mei, He Jun, Chen Jing, Zhou Peng, Shi Zhengli, Chen Xinwen, Xiong Xiaoli

Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus

基于复制缺陷型VSV的疫苗可诱导针对SARS-CoV-2和流感病毒的保护性免疫反应

Richard A Adeleke ,Julie Sahler ,Annette Choi ,Kyle Roth ,Viraj Upadhye ,Shahrzad Ezzatpour ,Brian Imbiakha ,Solomiia Khomandiak ,Annika Diaz ,Gary R Whittaker ,Mason C Jager ,Avery August ,David W Buchholz ,Hector C Aguilar

Interleukin-1 prevents SARS-CoV-2-induced membrane fusion to restrict viral transmission via induction of actin bundles

白细胞介素-1 通过诱导肌动蛋白束阻止 SARS-CoV-2 诱导的膜融合,从而限制病毒传播

Xu Zheng #, Shi Yu #, Yanqiu Zhou #, Kuai Yu #, Yuhui Gao, Mengdan Chen, Dong Duan, Yunyi Li, Xiaoxian Cui, Jiabin Mou, Yuying Yang, Xun Wang, Min Chen, Yaming Jiu, Jincun Zhao, Guangxun Meng

Glycosylphosphatidylinositol biosynthesis functions as a conserved host defense pathway against coronaviruses via regulation of LY6E.

糖基磷脂酰肌醇生物合成通过调节 LY6E 发挥保守的宿主防御途径对抗冠状病毒的作用

Ma Yanlong, Feng Fei, Feng Hui, Ma Xue, Wang Ziqiao, Han Yutong, Zhu Yunkai, Wang Yuyan, Gao Zhichao, Zhang Yuyuan, Ding Qiang, Zhao Jincun, Zhang Rong

TMEM106B Supports Viral Entry and Syncytia Formation Mediated by the Spike Proteins From Omicron BA.2.86 and JN.1.

TMEM106B 支持由 Omicron BA.2.86 和 JN.1 的刺突蛋白介导的病毒进入和合胞体形成

Wang Yuanyuan, Sun Hui, Liu Yuxin, Song Yanjun, Wang Weitong, Li Guoli, Zhang Jie, Zhang Yuanyuan, Chen Danying, Zhao Xuesen

Synergistic activation of bat SARS-like coronaviruses spike protein by elastase and TMPRSS2.

弹性蛋白酶和TMPRSS2协同激活蝙蝠SARS样冠状病毒刺突蛋白

Yamamoto Yuichiro, Inoue Tetsuya, Sugiyama Naoto, Furukawa Miyu, Sato Kaoru, Onodera Taishi, Takahashi Yoshimasa, Wakita Takaji, Fukasawa Masayoshi, Noguchi Kohji

UNC0638 inhibits SARS-CoV-2 entry by blocking cathepsin L maturation.

UNC0638 通过阻断组织蛋白酶 L 的成熟来抑制 SARS-CoV-2 的入侵

Chen Yongjun, Shi Yujin, Zuo Xiaoyan, Dong Xiaojing, Xiao Xia, Chen Lan, Xiang Zichun, Ren Lili, Zhou Zhuo, Wei Wensheng, Lei Xiaobo, Wang Jianwei

Simian Immunodeficiency Virus-Based Virus-like Particles Are an Efficient Tool to Induce Persistent Anti-SARS-CoV-2 Spike Neutralizing Antibodies and Specific T Cells in Mice.

基于猿猴免疫缺陷病毒的病毒样颗粒是诱导小鼠产生持久性抗SARS-CoV-2刺突中和抗体和特异性T细胞的有效工具

Gallinaro Alessandra, Falce Chiara, Pirillo Maria Franca, Borghi Martina, Grasso Felicia, Canitano Andrea, Cecchetti Serena, Baratella Marco, Michelini Zuleika, Mariotti Sabrina, Chiantore Maria Vincenza, Farina Iole, Di Virgilio Antonio, Tinari Antonella, Scarlatti Gabriella, Negri Donatella, Cara Andrea

Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants

SARS-CoV-2 BA.2.86 和 FLip 变体的免疫逃避、感染性和融合性

Panke Qu ,Kai Xu ,Julia N Faraone ,Negin Goodarzi ,Yi-Min Zheng ,Claire Carlin ,Joseph S Bednash ,Jeffrey C Horowitz ,Rama K Mallampalli ,Linda J Saif ,Eugene M Oltz ,Daniel Jones ,Richard J Gumina ,Shan-Lu Liu

SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl- concentration

SARS-CoV-2 包膜蛋白通过增加细胞内 Cl- 浓度损害气道上皮屏障功能并加剧气道炎症

Jian-Bang Xu #, Wei-Jie Guan #, Yi-Lin Zhang #, Zhuo-Er Qiu, Lei Chen, Xiao-Chun Hou, Junqing Yue, Yu-Yun Zhou, Jie Sheng, Lei Zhao, Yun-Xin Zhu, Jing Sun, Jincun Zhao, Wen-Liang Zhou, Nan-Shan Zhong
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 8